A substitution model of dietary manipulation is an effective means of optimising lipid profile, reducing C-reactive protein and increasing insulin-like growth factor-1

British Journal of Nutrition

Volumn 92, Issue 5, 2004, Pages 809-818

  Heald, Adrian H ^a   Golding, Cheryl ^b   Sharma, Reena ^a   Siddals, Kirk ^a   Kirk, Sara ^b   Lawton, Clare ^b   Anderson, Simon ^a   Gibson, J Martin ^a   Cade, Janet E ^b  

^a HOPE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

C reactive protein; Cardiovascular risk factors; Dietary interventions; Lipids; Substitution model

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; INSULIN; LIPID; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BODY FAT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DIET THERAPY; FAT INTAKE; FEMALE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; LIPID DIET; MODEL; POPULATION RESEARCH; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; STATISTICAL SIGNIFICANCE; VOLUNTEER; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADULT; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL; DIETARY FATS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIPIDS; RISK FACTORS; TRIGLYCERIDES; WEIGHT LOSS;

EID: 9444220859     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/BJN20041262     Document Type: Article

References (56)

1. Anonymous (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344, 1383-1389.
2. Astrup A, Buemann B, Western P, Toubro S, Raben A & Christensen NJ (1994) Obesity as an adaptation to a high-fat diet: evidence from a cross-sectional study. Am J Clin Nutr 59, 350-355.
3. Astrup A, Grunwald GK, Melanson EL, Saris WH & Hill JO (2000) The role of low-fat diets in body weight control: a meta-analysis of ad libitum dietary intervention studies. Int J Obes Relat Metab Dis 24, 1545-1552.
4. Bingham SA (1987) The dietary assessment of individuals; methods, accuracy, new techniques and recommendations. Nutr Abstr Rev 57A 705-742.
5. Blundell JE, Burley VJ, Cotton JR & Lawton CL (1993) Dietary fat and the control of energy intake: evaluating the effects of fat on meal size and post-meal satiety. Am J Clin Nutr 57, Suppl. 5, 772S-777S, 777S-778S.
6. Calvert C, Cade JE, Woodhouse A, Barrett J & UKWCS Steering Group (1996) Food frequency questionnaire (FFQ) interpretation and analysis: issues for the UK Women's Cohort Study. Proc Nutr Soc 56, 17A.
7. Caputo FA & Mattes RD (1992) Human dietary responses to covert manipulations of energy, fat, and carbohydrate in a midday meal. Am J Clin Nutr 56, 36-43.
8. Cooling J & Blundell JE (2000) Lean male high- and low-fat phenotypes - different routes for achieving energy balance. Int J Obesity 24, 1561-1566.
9. Crawley H (1988) Food Portion Sizes. London: H.M. Stationery Office.
10. Cruickshank JK, Heald AH, Anderson S, et al. (2001) Epidemiology of the insulin-like growth factor system in three ethnic groups. Am J Epidemiol 154, 504-513.
11. De Castro JM (1994) Methodology, correlation analysis, and interpretation of diet diary records of the food and fluid intake of free-living humans. Appetite 23, 179-192.
12. Department of Health (1999) Saving Lives: Our Healthier Nation. London: The Stationery Office.
13. DiClemente CC & Prochaska JO (1998) Toward a comprehensive, transtheoretical model of change: stages of change and addictive behaviors. In Treating Addictive Behaviors, 2nd ed. pp. 3-24 [WR Miller and N Heather, editors]. New York: Plenum Press.
14. Dittmar M (2003) Reliability and variability of bioimpedance measures in normal adults: effects of age, gender, and body mass. Am J Phys Anthropol 122, 361-370.
15. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W & Gotto AM Jr (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279, 1615-1622.
16. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP & Haffner SM (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102, 42-47.
17. Festa A, D'Agostino R Jr, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP & Haffner SM (2001) The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 25, 1407-1415.
18. Fidanza F, Puddu V, Imbimbo AB, Menotti A & Keys A (1970) Coronary heart disease in seven countries. VII. Five-year experience in rural Italy. Circulation 41, Suppl. 4, I63-I75.
19. Foltin RW, Rolls BJ, Moran TH, Kelly TH, McNelis AL & Fischman MW (1992a) Caloric, but not macronutrient, compensation by humans for required-eating occasions with meals and snack varying in fat and carbohydrate. Am J Clin Nutr 55, 331-342.
20. Foltin RW, Rolls BJ, Moran TH, Kelly TH, McNelis AL & Fischman MW (1992b) Caloric, but not macronutrient, compensation by humans for required-eating. Erratum. Am J Clin Nutr 56, 954.
21. Gorbach SL, Morrill-LaBrode A, Woods MN, et al. (1990) Changes in food patterns during a low-fat dietary intervention in women. J Am Diet Assoc 90, 802-809.
22. Grande F, Anderson JT & Keys A (1970) Comparison of effects of palmitic and stearic acids in the diet on serum cholesterol in man. Am J Clin Nutr 23, 1184-1193.
23. Greene GW & Rossi SR (1998) Stages of change for reducing dietary fat intake over 18 months. J Am Diet Assoc 98, 529-534.
24. Heald AH, Anderson SG, Ivison F, Laing I, Gibson JM & Cruickshank JK (2003a) C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groups. Atherosclerosis 170, 79-86.
25. Heald AH, Cade JE, Cruickshank JK, Anderson S, White A & Gibson JM (2003b) The influence of dietary intake on the insulin-like growth factor (IGF) system across three ethnic groups: a population-based study. Public Health Nutr 6, 175-181.
26. Heald AH, Cruickshank JK, Riste LK, et al. (2001) Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations. Diabetologia 44, 333-339.
27. Hellenius ML, Brismar KE, Berglund BH & de Faire U (1995) Effects on glucose tolerance, insulin secretion, insulin-like growth factor 1 and its binding protein, IGFBP-1, in a randomized controlled diet and exercise study in healthy, middle-aged men. J Intern Med 238, 121-130.
28. Hill JO, Seagle HM, Johnson SL, Smith S, Reed GW, Tran ZV, Cooper D, Stone M & Peters JC (1998) Effects of 14d of covert substitution of olestra for conventional fat on spontaneous food intake. Am J Clin Nutr 67, 1178-1185.
29. Holland B, Welch AA, Unwin ID, Buss DH, Paul AA & Southgate DAT (1991) McCance and Widdowson's The Composition of Foods, 5th ed. Cambridge and London: Royal Society of Chemistry and Ministry of Agriculture, Fisheries and Food.
30. Hooper L, Summerbell CD, Higgins JP, Thompson RL, Capps NE, Smith GD, Riemersma RA & Ebrahim S (2001) Dietary fat intake and prevention of cardiovascular disease. BMJ 322, 757-763.
31. Jackson SL, Golding C, Greenwood DC, Cade JE & Hirst SE (2002) Development of a new cut-off point to distinguish between high-fat and medium-fat consumers using the Dietary Instrument for Nutrition Education questionnaire. Proc Nutr Soc 61, 138A.
32. Janssen JAMJL, Stolk RP, Pols HAP, Grobbee DE & Lamberts SWJ (1998) Serum total IGF-I, free IGF-I and IGFBP-1 levels in an elderly population. Arterioscler Thromb Vasc Biol 18, 277-282.
33. Kaaks R, Bellati C, Venturelli E, Rinaldi S, Secreto G, Biessy C, Pala V, Sieri S & Berrino F (2003) Effects of dietary intervention on IGF-I and IGF-binding proteins, and related alterations in sex steroid metabolism: the Diet and Androgens (DIANA) Randomised Trial. Eur J Clin Nutr 57, 1079-1088.
34. Keenan DP, Achterberg C, Kris-Etherton PM, AbuSabha R & Von Eye A (1996) Use of qualitative and quantitative methods to define behavioral fat-reduction strategies and their relationship to dietary fat reduction in the patterns of dietary change study. J Am Diet Assoc 96, 1245-1250, 1253.
35. Keys A (1975) Coronary heart disease - the global picture. Atherosclerosis 22, 149-192.
36. Kristal AR, White E, Shattuck AL, Curry S, Anderson GL, Fowler A & Urban N (1992) Long-term maintenance of a low-fat diet: durability of fat-related dietary habits in the Women's Health Trial. J Am Diet Assoc 92, 553-559.
37. Lawton CL, Delargy HJ, Smith FC, Hamilton V & Blundell JE (1998) A medium-term intervention study on the impact of high- and low-fat snacks varying in sweetness and fat content: large shifts in daily fat intake but good compensation for daily energy intake. Br J Nutr 80, 49-61.
38. Lloyd HM, Paisley CM & Mela DJ (1995) Barriers to the adoption of reduced-fat diets in a UK population. J Am Diet Assoc 95, 316-322.
39. Marckmann P, Sandstrom B & Jespersen J (1994) Low-fat, high-fiber diet favorably affects several independent risk markers of ischemic heart disease: observations on blood lipids, coagulation, and fibrinolysis from a trial of middle-aged Danes. Am J Clin Nutr 59, 935-939.
40. Matthews DR, Hosker JB, Rudenski AS, Naylor BA, Treacher DF & Turner RC (1985) Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
41. Pao CI, Farmer PK, Begovic S, Goldstein S, Wu GJ & Phillips LS (1992) Expression of hepatic insulin-like growth factor-I and insulin-like growth factor binding protein-1 genes is transcriptionally regulated in streptozotocin-diabetic rats. Mol Endocrinol 6, 969-977.
42. Phillips LS, Goldstein S & Pao CI (1991) Nutrition and somatomedin. XXVI. Molecular regulation of IGF-I by insulin in cultured rat hepatocytes. Diabetes 40, 1525-1530.
43. Pirozzo S, Summerbell C, Cameron C & Glasziou P (2003) Should we recommend low fat diets for obesity? Obes Rev 4, 83-90.
44. Rallidis LS, Paschos G, Liakos GK, Velissaridou AH, Anastasiadis G & Zampelas A (2003) Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis 167, 237-242.
45. Ridker PM, Buring JE, Cook NR & Nader Rifai N (2003) C-Reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 107, 391-397.
46. Ridker PM, Hennekens H, Buring JE & Rifai N (2000) C-reactive protein and other markers of inflammation in prediction of cardiovascular disease in women. Circulation 342, 836-843.
47. Roe L, Strong C, Whiteside C, Neil A & Mant D (1994) Dietary intervention in primary care: validity of the DINE method for diet assessment. Fam Pract 11, 375-381.
48. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB & Wareham NJ (2002) Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 359, 1740-1745.
49. Sever PS, Dahlof B, Poulter NR, et al. (2003) Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 361, 1149-1158.
50. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH & Packard CJ (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 333, 1301-1307.
51. Stephenson J & Imrie J (1998) Why do we need randomised controlled trials to assess behavioural interventions? BMJ 316 611-613.
52. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, Lamberts SW, Oostra BA, Pols HA & van Duijn CM (2001) A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 50, 637-642.
53. Walker KZ, O'Dea K, Johnson L, Sinclair AJ, Piers LS, Nicholson GC & Muir JG (1996) Body fat distribution and non-insulin-dependent diabetes: comparison of a fiber-rich, high-carbohydrate, low-fat (23 %) diet and a 35 % fat diet high in monounsaturated fat. Am J Clin Nutr 63, 254-260.
54. Westwood M, Gibson JM, Davies AJ, Young RJ & White A (1994) The phosphorylation pattern of insulin-like growth factor binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. J Clin Endocrinol Metab 79, 1735-1741.
55. White E, Shattuck AL, Kristal AR, Urban N, Prentice RL, Henderson MM, Insull W Jr, Moskowitz M, Goldman S & Woods MN (1992) Maintenance of a low-fat diet: follow-up of the Women's Health Trial. Cancer Epidemiol Biomarkers Prev 1, 315-323.
56. Wood DA, Durrington P, McInnes G, Poulter N, Rees A & Wray R (1998) Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 80, S1-S29.